Showing results (3791-3800 of 9,925) with videos related to
Sort By:
Pageof 993
Bone Marrow Transplantation|April 7, 2005
Allogeneic haematopoietic stem cell transplantation in children with acute lymphoblastic leukaemia: the BFM/IBFM/EBMT conceptsC Peters, A Schrauder, M Schrappe, et al.Bone Marrow Transplantation|February 1, 1992
Evaluation of doxorubicin in combination with mafosfamide for in vitro elimination of myeloid and lymphoid tumor cells from human bone marrowJ Domenech, M T Georget, E Gihana, et al.Bone Marrow Transplantation|February 1, 1992
Allogeneic marrow transplantation using T cell depletion for patients with juvenile chronic myelogenous leukemia without HLA-identical siblingsN J Bunin, J T Casper, C Lawton, et al.Bone Marrow Transplantation|February 1, 1992
Epidermolysis bullosa acquisita, a rare late complication of allogeneic bone marrow transplantation?J Burger, J Gmür, L Bruckner-TudermanBone Marrow Transplantation|January 25, 2005
Circulating dendritic cell subset levels after allogeneic stem cell transplantation in children correlate with time post transplant and severity of acute graft-versus-host diseaseJ Vakkila, A W Thomson, L Hovi, et al.Bone Marrow Transplantation|January 25, 2005
Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skinT Wetzig, M Sticherling, J-C Simon, et al.Bone Marrow Transplantation|August 10, 2004
Cyclosporine alone vs cyclosporine plus methotrexate for post-transplant immunosuppression after HLA-identical sibling bone marrow transplantation: a randomized prospective studyK-H Lee, S-J Choi, J-H Lee, et al.Bone Marrow Transplantation|July 20, 2004
Telomere length predicts neutrophil recovery in the absence of G-CSF after autologous peripheral blood stem cell transplantationL F Lincz, F E Scorgie, J A Sakoff, et al.Bone Marrow Transplantation|August 1, 1992
Thyroid function after autologous bone marrow transplantationK Carlson, G Lönnerholm, B Smedmyr, et al.Bone Marrow Transplantation|June 1, 2004
A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphomaL Arcaini, E Orlandi, E P Alessandrino, et al.Pageof 993